CC on NYSE

Chemours

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons⁵

American chemical company

The Chemours Company (kem-ORZ), headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins.³ Its shares trade on NYSE under the symbol CC.¹ Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

2015Founded¹

Compare with Huntsman Corporation, Olin Corporation or Solstice Advanced Materials Inc., or pick any stock.

TickerCC on NYSE¹
Industrychemical industry¹
HeadquartersWilmington¹
Websitechemours.com
Legal formDelaware corporation¹
Incorporated inDE⁶
Business address1007 Market Street, Wilmington, De 19801⁶
Filer categoryLarge accelerated filer⁶
LEI549300M1BOLNXL8DOV14⁴
StatusActive⁴
LEI statusIssued and current⁴
Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States⁴
Registered withDivision of Corporations, Department of State, 5483465⁴

See how the biggest companies compare on our leaderboards

The Chemours Company (kem-ORZ), headquartered in Wilmington, Delaware, is an American chemical company. It was spun off from DuPont in July 2015. The company's primary products are refrigerants, titanium dioxide pigment, and industrial fluoropolymer resins. The company operates 28 major production facilities in 8 countries and serves approximately 2,400 customers in approximately 110 countries.³

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

15.5%Gross margin¹⁰

-6.6%Net margin¹⁰

0.4%Revenue growth, 2025¹⁰

-154.4%Return on equity¹⁰

16.40×Debt to equity¹⁰

$51.0MFree cash flow¹⁰

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Titanium Technologies brought in 42% of the revenue Chemours broke down this way in fiscal 2025.

Titanium Technologies$2.4B¹⁰42%down 6% from 2024
Thermal And Specialized Solutions$2.1B¹⁰36%up 13% from 2024
Advanced Performance Materials$1.3B¹⁰22%down 5% from 2024
Other Non-Reportable$50.0M¹⁰1%down 7% from 2024

Business segments by year

Business segments	2023	2024	2025
Titanium Technologies	$2.7B	$2.6B	$2.4B
Thermal And Specialized Solutions	$1.9B	$1.8B	$2.1B
Advanced Performance Materials	$1.5B	$1.3B	$1.3B
Other Non-Reportable	$85.0M	$54.0M	$50.0M

Regions

North America brought in 46% of the revenue Chemours broke down this way in fiscal 2025.

North America$2.7B¹⁰46%up 3% from 2024
Asia Pacific$1.2B¹⁰21%down 10% from 2024
EMEA$1.2B¹⁰20%up 2% from 2024
Latin America$748.0M¹⁰13%up 12% from 2024

Regions by year

Regions	2023	2024	2025
North America	$2.7B	$2.6B	$2.7B
Asia Pacific	$1.5B	$1.4B	$1.2B
EMEA	$1.2B	$1.1B	$1.2B
Latin America	$674.0M	$669.0M	$748.0M

Where the money goes

Where each dollar of revenue went, fiscal 2025

Cost of revenueSelling, general and admin

Cost of revenue79¢$4.9B
Research and development2¢$108.0M
Selling, general and admin13¢$799.0M
Interest4¢$269.0M
Income tax2¢$109.0M

Out of $5.8B in revenue.¹⁰ The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

Capital spendingDividends paid

Capital spending73¢$213.0M
Dividends paid27¢$78.0M

Out of $264.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.¹⁰

Financial statements

Revenue¹¹¹²¹³¹⁴¹⁰$5.8B in 2025+5% since 2019

Gross profit¹¹¹²¹³¹⁴¹⁰$902.0M in 2025−15% since 2019

Net income¹¹¹²¹³¹⁴¹⁰-$386.0M in 2025+642% since 2019

Every line of the income statement as filed: the last 3 fiscal years (annual) or 8 quarters (quarterly), latest first.¹⁰

Period ending	2025-12-31	2024-12-31	2023-12-31
Net sales	$5.8B	$5.8B	$6.1B
Cost of goods sold	$4.9B	$4.6B	$4.8B
Gross profit	$902.0M	$1.1B	$1.3B
Selling, general, and administrative expense	$799.0M	$598.0M	$1.3B
Research and development expense	$108.0M	$109.0M	$108.0M
Restructuring, asset-related, and other charges	$59.0M	$60.0M	$153.0M
Goodwill impairment charge	$0	$56.0M
Total other operating expenses	$966.0M	$823.0M	$1.5B
Equity in earnings of affiliates	$35.0M	$43.0M	$45.0M
Interest expense, net	-$269.0M	-$263.0M	-$208.0M
Loss on extinguishment of debt	-$5.0M	-$1.0M	-$1.0M
Other income, net	$26.0M	$8.0M	$91.0M
(Loss) Income before income taxes	-$277.0M	$106.0M	-$318.0M
(Benefit from) provision for income taxes	$109.0M	$37.0M	-$66.0M
Net (loss) income	-$386.0M	$69.0M	-$252.0M
Less: Net income attributable to non-controlling interests			$1.0M
Net (loss) income attributable to Chemours	-$386.0M	$69.0M	-$253.0M
Basic (loss) earnings per share of common stock	-$2.57	$0.46	-$1.70
Diluted (loss) earnings per share of common stock	-$2.57	$0.46	-$1.70

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Net sales	$1.3B	$1.5B	$1.6B	$1.4B	$1.4B	$1.5B	$1.6B	$1.4B
Cost of goods sold	$1.2B	$1.3B	$1.3B	$1.1B	$1.1B	$1.2B	$1.2B	$1.1B
Gross profit					$265.0M
Selling, general, and administrative expense		$122.0M	$424.0M
Total other operating expenses		$152.0M	$470.0M
(Loss) Income before income taxes	-$67.0M	$38.0M	-$248.0M		$1.0M	-$32.0M	$69.0M	$70.0M
(Benefit from) provision for income taxes		-$8.0M	$131.0M	$5.0M	$12.0M
Net (loss) income	-$47.0M	$46.0M	-$379.0M	-$5.0M	-$11.0M	-$32.0M	$60.0M	$54.0M
Net (loss) income attributable to Chemours	-$47.0M	$46.0M	-$380.0M	-$5.0M	-$11.0M	-$32.0M	$60.0M	$54.0M
Basic (loss) earnings per share of common stock	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.40	$0.36
Diluted (loss) earnings per share of common stock	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.39	$0.36

Total assets¹¹¹²¹³¹⁴¹⁰$7.4B in 2025+2% since 2019

Total liabilities¹⁷¹¹¹²¹³¹⁰$7.1B in 2025+9% since 2019

Shareholders’ equity¹⁷¹¹¹²¹³¹⁰$250.0M in 2025−64% since 2019

Cash¹⁷¹¹¹³¹⁴¹⁰$670.0M in 2025−29% since 2019

Long-term debt¹⁷¹¹¹²¹³¹⁰$4.1B in 2025+2% since 2019

Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 7 quarters (quarterly), latest first.¹⁰

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Cash and cash equivalents	$670.0M				$713.0M
Restricted cash and restricted cash equivalents	$2.0M
Accounts and notes receivable, net	$679.0M				$770.0M
Inventories	$1.6B				$1.5B
Prepaid expenses and other	$80.0M				$71.0M
Assets held for sale	$1.0M
Total current assets	$3.0B				$3.0B
Property, plant, and equipment	$9.9B	$9.8B	$9.8B	$9.6B	$9.6B
Less: Accumulated depreciation	-$6.8B				-$6.4B
Property, plant, and equipment, net	$3.1B	$3.1B	$3.1B	$3.1B	$3.2B
Operating lease right-of-use assets	$271.0M	$273.0M	$275.0M	$281.0M	$265.0M
Goodwill	$46.0M				$46.0M
Other intangible assets, net	$2.0M				$3.0M
Investments in affiliates	$160.0M				$152.0M
Assets held for sale, non-current	$21.0M
Restricted cash and restricted cash equivalents	$52.0M				$50.0M
Other assets	$751.0M	$690.0M	$684.0M	$764.0M	$788.0M
Total assets	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B
Accounts payable	$954.0M				$1.2B
Compensation and other employee-related cost	$96.0M				$99.0M
Short-term and current maturities of long-term debt	$42.0M				$54.0M
Current environmental remediation	$88.0M				$115.0M
Other accrued liabilities	$506.0M	$580.0M	$585.0M	$396.0M	$396.0M
Total current liabilities	$1.7B	$1.9B	$1.8B	$1.7B	$1.8B
Long-term debt, net	$4.1B	$4.1B	$4.1B	$4.1B	$4.1B
Operating lease liabilities	$191.0M	$197.0M	$201.0M	$208.0M	$198.0M
Long-term environmental remediation	$530.0M				$456.0M
Deferred income taxes	$37.0M	$27.0M	$28.0M		$35.0M
Other liabilities	$588.0M				$369.0M
Total liabilities	$7.1B		$7.2B	$6.8B	$6.9B
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025; 198,300,033 shares issued and 149,428,431 shares outstanding at December 31, 2024)	$2.0M				$2.0M
Treasury stock, at cost (48,826,793 shares at December 31, 2025; 48,871,602 shares at December 31, 2024)	-$1.8B				-$1.8B
Additional paid-in capital	$1.1B				$1.1B
Retained earnings	$1.2B	$1.3B	$1.2B	$1.6B	$1.7B
Accumulated other comprehensive loss	-$244.0M	-$278.0M	-$286.0M	-$334.0M	-$367.0M
Total Chemours stockholders equity	$250.0M	$274.0M	$228.0M	$566.0M	$571.0M
Non-controlling interests	$1.0M				$1.0M
Total equity	$251.0M	$276.0M	$230.0M	$567.0M	$572.0M
Total liabilities and equity	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B
Common stock , par value (USD per share)	$0.01				$0.01
Common stock, shares authorized (in shares)	810.0M shares				810.0M shares
Common stock, shares Issued (in shares)	198.7M shares				198.3M shares
Common stock, shares outstanding (in shares)	149.9M shares				149.4M shares
Treasury stock (in shares)	48.8M shares				48.9M shares

Period ending	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$670.0M				$713.0M	$1.2B
Restricted cash and restricted cash equivalents	$2.0M
Accounts and notes receivable, net	$679.0M				$770.0M	$622.0M
Inventories	$1.6B				$1.5B	$1.3B
Prepaid expenses and other	$80.0M				$71.0M
Assets held for sale	$1.0M
Total current assets	$3.0B				$3.0B	$3.8B
Property, plant, and equipment	$9.9B	$9.8B	$9.8B	$9.6B	$9.6B
Less: Accumulated depreciation	-$6.8B				-$6.4B	-$6.2B
Property, plant, and equipment, net	$3.1B	$3.1B	$3.1B	$3.1B	$3.2B	$3.2B
Operating lease right-of-use assets	$271.0M	$273.0M	$275.0M	$281.0M	$265.0M	$263.0M
Goodwill	$46.0M				$46.0M
Other intangible assets, net	$2.0M				$3.0M
Investments in affiliates	$160.0M				$152.0M	$158.0M	$175.0M
Assets held for sale, non-current	$21.0M
Restricted cash and restricted cash equivalents	$52.0M				$50.0M
Other assets	$751.0M	$690.0M	$684.0M	$764.0M	$788.0M	$664.0M
Total assets	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B	$8.2B
Accounts payable	$954.0M				$1.2B
Compensation and other employee-related cost	$96.0M				$99.0M
Short-term and current maturities of long-term debt	$42.0M				$54.0M
Current environmental remediation	$88.0M				$115.0M
Other accrued liabilities	$506.0M	$580.0M	$585.0M	$396.0M	$396.0M	$1.1B
Total current liabilities	$1.7B	$1.9B	$1.8B	$1.7B	$1.8B	$2.5B
Long-term debt, net	$4.1B	$4.1B	$4.1B	$4.1B	$4.1B	$4.0B
Operating lease liabilities	$191.0M	$197.0M	$201.0M	$208.0M	$198.0M	$208.0M
Long-term environmental remediation	$530.0M				$456.0M
Deferred income taxes	$37.0M	$27.0M	$28.0M		$35.0M
Other liabilities	$588.0M				$369.0M	$329.0M
Total liabilities	$7.1B		$7.2B	$6.8B	$6.9B	$7.5B
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025; 198,300,033 shares issued and 149,428,431 shares outstanding at December 31, 2024)	$2.0M				$2.0M
Treasury stock, at cost (48,826,793 shares at December 31, 2025; 48,871,602 shares at December 31, 2024)	-$1.8B				-$1.8B
Additional paid-in capital	$1.1B				$1.1B
Retained earnings	$1.2B	$1.3B	$1.2B	$1.6B	$1.7B
Accumulated other comprehensive loss	-$244.0M	-$278.0M	-$286.0M	-$334.0M	-$367.0M
Total Chemours stockholders equity	$250.0M	$274.0M	$228.0M	$566.0M	$571.0M	$721.0M
Non-controlling interests	$1.0M				$1.0M
Total equity	$251.0M	$276.0M	$230.0M	$567.0M	$572.0M	$723.0M	$1.1B
Total liabilities and equity	$7.4B	$7.5B	$7.5B	$7.4B	$7.5B	$8.2B
Common stock , par value (USD per share)	$0.01				$0.01
Common stock, shares authorized (in shares)	810.0M shares				810.0M shares
Common stock, shares Issued (in shares)	198.7M shares				198.3M shares
Common stock, shares outstanding (in shares)	149.9M shares				149.4M shares
Treasury stock (in shares)	48.8M shares				48.9M shares

Cash from operations¹¹¹²¹³¹⁴¹⁰$264.0M in 2025−59% since 2019

Capital spending¹¹¹²¹³¹⁴¹⁰$213.0M in 2025−56% since 2019

Free cash flow¹¹¹²¹³¹⁴¹⁰$51.0M in 2025−70% since 2019

Dividends paid¹⁸¹²¹³¹⁴¹⁰$78.0M in 2025−52% since 2019

Share buybacks¹¹¹²¹³¹⁴¹⁰$69.0M in 2023−79% since 2019

Every line of the cash flow as filed: the last 3 fiscal years, latest first.¹⁰

Period ending	2025-12-31	2024-12-31	2023-12-31
Net (loss) income	-$386.0M	$69.0M	-$252.0M
Depreciation and amortization	$340.0M	$292.0M	$309.0M
Gain on sales of assets and businesses, net	-$8.0M	-$3.0M	-$110.0M
Equity in earnings of affiliates, net	-$7.0M	-$1.0M	$11.0M
Loss (gain) on extinguishment of debt	$5.0M	$1.0M	$1.0M
Amortization of debt issuance costs and issue discounts	$11.0M	$12.0M	$9.0M
Deferred tax provision (benefit)	$64.0M	-$31.0M	-$143.0M
Asset-related charges	$32.0M	$27.0M	$95.0M
Stock-based compensation expense	$21.0M	$15.0M	$18.0M
Net periodic pension (income) cost	-$2.0M	$6.0M	$9.0M
Defined benefit plan contributions	-$2.0M	-$12.0M	-$10.0M
Other operating charges and credits, net	$18.0M	-$42.0M	$1.0M
Goodwill impairments	$0	$56.0M
Accounts and notes receivable, net	$106.0M	-$139.0M	-$14.0M
Inventories and other current operating assets	-$106.0M	-$140.0M	$61.0M
Other non-current operating assets	$66.0M	-$98.0M
Accounts payable	-$165.0M	$4.0M	-$74.0M
Other current operating liabilities	-$3.0M	-$660.0M	$642.0M
Non-current operating liabilities	$280.0M	$11.0M	$3.0M
Cash provided by (used for) operating activities	$264.0M	-$633.0M	$556.0M
Purchases of property, plant, and equipment	-$213.0M	-$360.0M	-$370.0M
Proceeds from sales of assets and businesses, net of cash divested	$7.0M	$3.0M	$143.0M
Foreign exchange contract settlements, net	-$1.0M	$2.0M	-$8.0M
Other investing activities	$1.0M	$2.0M	$6.0M
Cash used for investing activities	-$206.0M	-$353.0M	-$229.0M
Proceeds from issuance of debt, net	$748.0M	$606.0M	$648.0M
Debt repayments	-$787.0M	-$490.0M	-$280.0M
Payments of debt issuance costs	-$7.0M	-$9.0M	-$4.0M
Payments on finance leases	-$14.0M	-$12.0M	-$11.0M
Proceeds from supplier financing programs	$80.0M	$93.0M	$123.0M
Payments to supplier financing program	-$88.0M	-$102.0M	-$87.0M
Purchases of treasury stock, at cost			-$69.0M
Proceeds from exercised stock options		$9.0M	$19.0M
Payments related to tax withheld on vested stock awards	-$1.0M	-$3.0M	-$19.0M
Payments of dividends to the Company's common shareholders	-$78.0M	-$148.0M	-$149.0M
(Distributions to) cash received from non-controlling interest shareholders		-$1.0M	$1.0M
Other financing activities	$21.0M	$21.0M
Cash (used for) provided by financing activities	-$126.0M	-$36.0M	$172.0M
Effect of exchange rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents	$29.0M	-$22.0M	$4.0M
(Decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents	-$39.0M	-$1.0B	$503.0M
Interest, net of amounts capitalized	$251.0M	$267.0M	$223.0M
Income taxes, net of refunds	$74.0M	$82.0M	$63.0M
Purchases of property, plant, and equipment included in accounts payable	$33.0M	$88.0M	$82.0M

Compare Chemours with another company

Corporate structure

Chemours sits at the top of its group. 52 entities, 25 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Chemours

VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Chemours, latest Apr 29, 2026
VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Chemours, latest Apr 29, 2026
BlackRock Filed SCHEDULE 13G/A on Chemours, latest Apr 24, 2026 (8 filings since Feb 3, 2022)
VANGUARD GROUP INC Filed SCHEDULE 13G/A on Chemours, latest Mar 26, 2026 (6 filings since Feb 9, 2022)
MILLENNIUM MANAGEMENT LLC Filed SCHEDULE 13G/A on Chemours, latest Aug 8, 2025 (2 filings since Jun 10, 2025)
FMR LLC Filed SCHEDULE 13G/A on Chemours, latest Aug 6, 2025 (10 filings since Nov 10, 2021)
Sessa Capital (Master), L.P. Filed SC 13G/A on Chemours, latest Feb 14, 2023 (2 filings since Feb 14, 2022)

Chemours Wilmington, Delaware, United States
- 2463297 Ontario Limited Subsidiary · Canada
- Chemours Belgium BVBA Subsidiary · Belgium
- Chemours Deutschland GmbH Subsidiary · Germany
- Chemours France SAS Subsidiary · France
- Chemours Hong Kong Holding Limited Subsidiary · Hong Kong
- Chemours International B.V. Subsidiary · Netherlands
- Chemours International Operations Sàrl Subsidiary · Switzerland
- Chemours Italy S.r.l. Subsidiary · Italy
- Chemours Kabushiki Kaisha Subsidiary · Japan
- Chemours Netherlands B.V. Subsidiary · Netherlands
- Chemours NL Holding 1 B.V. Subsidiary · Netherlands
- Chemours NL Holding 2 B.V. Subsidiary · Netherlands
- Chemours NL Holding 4 B.V. Subsidiary · Netherlands
- Chemours Services Sàrl Subsidiary · Switzerland
- Chemours Spain S.L. Subsidiary · Spain
- Chemours Titanium Technologies (Taiwan) Ltd. Subsidiary · Taiwan
- Chemours TR Kimyasal Ürünler Limited Şirketi Subsidiary · Turkey
- Chemours UK Limited Subsidiary · United Kingdom
- Chemours Vietnam Company Limited Subsidiary · Vietnam
- First Chemical Holdings, LLC Subsidiary · Mississippi, United States
- First Chemical Texas, L.P Subsidiary · Delaware, United States
- FT Chemical, Inc. Subsidiary · Texas, United States
- ICOR International Inc. Subsidiary · Indiana, United States
- Initiatives Inc de México S.A. de C.V. Subsidiary · Mexico
- Noluma International, LLC Subsidiary · Delaware, United States
- and 26 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Chemours reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Item	Latest	A year before	Change
Property and equipment, before depreciation	$9.9B¹⁰ Dec 31, 2025	$9.6B¹⁰ Dec 31, 2024	+3.6%
Accumulated depreciation	$6.8B¹⁰ Dec 31, 2025	$6.4B¹⁰ Dec 31, 2024	+7.1%
Property and equipment, net	$3.1B¹⁰ Dec 31, 2025	$3.2B¹⁰ Dec 31, 2024	−3.5%
Finance-lease assets	$43.0M¹⁰ Dec 31, 2025	$53.0M¹⁰ Dec 31, 2024	−18.9%
Operating-lease assets (leased space)	$271.0M¹⁰ Dec 31, 2025	$265.0M¹⁰ Dec 31, 2024	+2.3%

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$670.0M¹⁰ Dec 31, 2025	$713.0M¹⁰ Dec 31, 2024	−6.0%
Stakes in other companies (equity method)	$160.0M¹⁰ Dec 31, 2025	$152.0M¹⁰ Dec 31, 2024	+5.3%

Intangibles and goodwill

Item	Latest	A year before	Change
Goodwill	$46.0M¹⁰ Dec 31, 2025	$46.0M¹⁰ Dec 31, 2024	0%
Finite-lived intangibles, gross	$59.0M¹⁰ Dec 31, 2025	$59.0M¹⁰ Dec 31, 2024	0%
Accumulated amortization	$57.0M¹⁰ Dec 31, 2025	$56.0M¹⁰ Dec 31, 2024	+1.8%
Finite-lived intangibles, net	$2.0M¹⁰ Dec 31, 2025	$3.0M¹⁰ Dec 31, 2024	−33.3%

Inventory

Item	Latest	A year before	Change
Inventory, total	$1.6B¹⁰ Dec 31, 2025	$1.5B¹⁰ Dec 31, 2024	+7.2%
Work in process	$259.0M¹⁰ Dec 31, 2025	$271.0M¹⁰ Dec 31, 2024	−4.4%
Finished goods	$875.0M¹⁰ Dec 31, 2025	$889.0M¹⁰ Dec 31, 2024	−1.6%

Properties, in its own words

Our Production Facilities and Technical Centers

Our corporate headquarters is located in Wilmington, Delaware, and we maintain a global network of production facilities and technical centers located in cost-effective and strategic locations. We also use contract manufacturing and joint venture partners in order to provide regional access or to lower manufacturing costs, as appropriate.

The rest of Item 2

The following chart sets forth our production facilities at December 31, 2025.

Production Facilities

Region · Thermal & Specialized Solutions · Titanium Technologies · Advanced Performance Materials · Shared Locations

North America · Corpus Christi, TexasEl Dorado, Arkansas (1)LaPorte, Texas (1)Louisville, Kentucky (1) · DeLisle, MississippiNew Johnsonville, TennesseeJesup, Georgia (Mine) (1)Nahunta, Georgia (Mine) (1)Offerman, Georgia (Mineral Separation)Starke, Florida (Mine & Mineral Separation) · Deepwater, New JerseyElkton, Maryland (1)Fayetteville, North CarolinaLouisville, KentuckyParlin, New Jersey (1)Washington, West Virginia · Belle, West Virginia (3)

Europe, the Middle East, and Africa · Mechelen, BelgiumVillers St. Paul, France (1) · Dordrecht, Netherlands (4)

Latin America · Barueri, Brazil (1)Manaus, Brazil (1)Monterrey, Mexico (1) · Altamira, Mexico

Asia Pacific · Chiba, Japan (2) · Shimizu, Japan (2)Sichuan, China (2) · Changshu, China (2) (4)

Site is leased from a third party.

Site with joint venture equity affiliates.

Shared site between the Thermal & Specialized Solutions and Other segments.

Shared site between the Thermal & Specialized Solutions and Advanced Performance Materials segments.

We have technical centers and R&D facilities located at a number of our production facilities. We also maintain stand-alone technical centers to serve our customers and provide technical support.

The following chart sets forth our stand-alone technical centers at December 31, 2025.

Technical Centers

Region · Thermal & Specialized Solutions · Titanium Technologies · Advanced Performance Materials · Shared Locations

North America · Newark, Delaware (1) (4)Wilmington, Delaware (1) (3)

Europe, the Middle East, and Africa · Kallo, Belgium (1) · Meyrin, Switzerland (1) (3)

Latin America · Mexico City, Mexico (1)

Asia Pacific · Shimizu, Japan (2) · Shanghai, China (1) (4)

Site is leased from a third party.

Site with joint venture equity affiliates.

Shared site between the Thermal & Specialized Solutions and Advanced Performance Materials segments.

Shared site between the Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials segments.

Our plants and equipment are maintained in good operating condition. We believe that we have sufficient production capacity for our primary products to meet demand in 2026. Our properties are primarily owned by us; however, certain properties are leased, as noted in the preceding tables.

We recognize that the security and safety of our operations are critical to our employees and communities, as well as our future. Physical security measures have been combined with process safety measures, administrative procedures, and emergency response preparedness into an integrated security plan. We conduct vulnerability assessments at our operating facilities in the U.S., as well as high-priority sites worldwide, and as a result, identify and implement the appropriate measures to protect these facilities from physical and cyberattacks. We also maintain preparedness plans that detail actions needed to recover from acute severe weather events, natural disasters, or other events that could disrupt our business. We engineer our

facilities to better withstand these events and hold insurance coverage to protect against losses from physical damages and business interruptions. These measures have historically been in place, and these activities and associated costs are driven by normal operational preparedness.

Item 2 of the 10-K filed Feb 24, 2026.¹⁹

The story

On July 1, 2015, DuPont completed the corporate spin-off of Chemours, which began trading on the New York Stock Exchange.

Chemours assumed various liabilities arising from lawsuits against DuPont.

In February 2024, CEO Mark Newman, CFO Jonathan Lock, and Financial Controller Camela Wisel were placed on administrative leave by the board of directors due to delayed payments to some vendors to increase their bonuses, in violation of the company's standards for ethics.

From Wikipedia’s article on Chemours, shared under CC BY-SA 4.0.⁷

Leadership

Who has led Chemours, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

20202025

Chief executive officerDenise Dignam Mar 5, 2024 to now²⁰
Chief executive officerMark P. Vergnano Jun 17, 2015 to Mar 3, 2021²¹
PresidentJoseph T. Martinko Aug 2, 2023 to Aug 5, 2024²²
PresidentAlisha Bellezza Mar 1, 2021 to Mar 10, 2023²³
PresidentDenise Dignam Mar 1, 2021 to Aug 2, 2023²⁴
PresidentEdwin C. Sparks Apr 10, 2018 to Mar 10, 2023²⁵
PresidentPaul Kirsch Jun 24, 2016 to Mar 6, 2019²⁶
PresidentMichael P. Heffernan Jun 17, 2015 to Jun 17, 2015²⁷
PresidentE. Bryan Snell Jul 6, 2015 to Mar 3, 2021²⁸
PresidentMark P. Vergnano Jul 6, 2015 to Mar 3, 2021²⁹
PresidentThierry Fj Vanlancker Jul 6, 2015 to Mar 3, 2016³⁰
PresidentChristian W. Siemer Sep 10, 2015 to Feb 6, 2018³¹
Chief financial officerMatthew S. Abbott Mar 5, 2024 to May 10, 2024³²
Chief financial officerShane Hostetter Jul 2, 2024 to now³³
Chief financial officerSameer Ralhan Jun 5, 2019 to Mar 10, 2023³⁴

Board members and other officers (44)

OfficerDamian Gumpel Mar 4, 2025 to now³⁵
OfficerJoseph T. Martinko Mar 4, 2025 to now³⁶
Interim Pres. - Titanium TechDiane I. Picho Mar 29, 2024 to now³⁷
Chief Accounting OfficerDavid Will Aug 13, 2024 to now³⁸
Pres Advanced Performance MatCalderon Gerardo Familiar Apr 4, 2023 to now³⁹
SVP, President, Titanium TechnDenise Dignam Aug 3, 2023 to now⁴⁰
Senior Vice President, PeopleRon Christopher Charles Oct 3, 2023 to May 10, 2024⁴¹
SVP, GC & Corp. SecretaryKristine M. Wellman Oct 7, 2022 to now⁴²
VP, CAO & ControllerCamela Wisel Oct 1, 2021 to Aug 3, 2023⁴³
SVP, Chief Development OfficerJonathan Lock Nov 10, 2021 to Aug 3, 2023⁴⁴
SVP Corp Communications & CBOAlvenia Scarborough Oct 2, 2020 to now⁴⁵
VP, CAO & ControllerMatthew S. Abbott Aug 22, 2019 to Aug 5, 2024⁴⁶
Senior VP of Human ResourcesSusan M. Kelliher Jun 5, 2017 to Mar 10, 2023⁴⁷
Pres Fluoroproducts(Designate)Paul Kirsch Jun 3, 2016 to Jun 3, 2016⁴⁸
Controller (Designate)Amy Trojanowski Jun 17, 2015 to Mar 15, 2019⁴⁹
Pres Chem Solution (Designate)Christian W. Siemer Jun 17, 2015 to Mar 3, 2016⁵⁰
GC and Corp. Sec. (Designate)David C. Shelton Jun 17, 2015 to May 9, 2022⁵¹
Pres Titanium Tech (Designate)E. Bryan Snell Jun 17, 2015 to Jun 17, 2015⁵²
Sr. VP - HR (Designate)Elizabeth Albright Jun 17, 2015 to Mar 10, 2017⁵³
VP Corp Comm & CBO (Desginate)Erich Parker Jun 17, 2015 to Mar 4, 2020⁵⁴
VP & Asst. TreasurerNigel Pond Jun 17, 2015 to Jun 17, 2015⁵⁵
Vice PresidentSteven Zelac Jun 17, 2015 to Jun 17, 2015⁵⁶
Pres Fluoroproduct (Designate)Thierry Fj Vanlancker Jun 17, 2015 to Jun 17, 2015⁵⁷
Board memberJoseph Daniel Kava Jan 13, 2025 to now⁵⁸
Board memberLeslie M. Turner Feb 19, 2025 to now⁵⁹
Board memberCourtney Mather Apr 24, 2025 to now⁶⁰
Board memberGeorge R. Brokaw Apr 24, 2025 to now⁶¹
Board memberDenise Dignam Mar 29, 2024 to now⁶²
Board memberLivingston Satterthwaite Jun 20, 2024 to now⁶³
Board memberAlister Cowan Dec 4, 2023 to now⁶⁴
Board memberSandra L. Phillips Oct 1, 2021 to Jan 3, 2024⁶⁵
Board memberErin N. Kane Jun 27, 2019 to now⁶⁶
Board memberSean D. Keohane May 4, 2018 to now⁶⁷
Board memberMichael P. Heffernan Jun 17, 2015 to Jun 17, 2015²⁷
Board memberNigel Pond Jun 17, 2015 to Jun 17, 2015⁵⁵
Board memberSteven Zelac Jun 17, 2015 to Jun 17, 2015⁵⁶
Board memberCurtis J. Crawford Jun 19, 2015 to Apr 28, 2023⁶⁸
Board memberBradley J. Bell Jul 1, 2015 to Apr 29, 2022⁶⁹
Board memberCurt Anastasio Jul 1, 2015 to Aug 7, 2024⁷⁰
Board memberDawn L. Farrell Jul 1, 2015 to now⁷¹
Board memberMary B. Cranston Jul 1, 2015 to now⁷²
Board memberRichard H. Brown Jul 1, 2015 to Apr 30, 2021⁷³
Board memberStephen D. Newlin Jul 1, 2015 to Apr 28, 2017⁷⁴
Board memberMark P. Vergnano Jul 6, 2015 to Mar 3, 2022²⁹

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

2463297 Ontario Limited Canada⁸
Chemours Belgium BVBA Belgium⁸
Chemours Deutschland GmbH Germany⁸
Chemours France SAS France⁸
Chemours Hong Kong Holding Limited Hong Kong⁸
Chemours International B.V. Netherlands⁸
Chemours International Operations Sàrl Switzerland⁸
Chemours Italy S.r.l. Italy⁸
Chemours Kabushiki Kaisha Japan⁸
Chemours NL Holding 1 B.V. Netherlands⁸
Chemours NL Holding 2 B.V. Netherlands⁸
Chemours NL Holding 4 B.V. Netherlands⁸
Chemours Netherlands B.V. Netherlands⁸
Chemours Services Sàrl Switzerland⁸
Chemours Spain S.L. Spain⁸
Chemours TR Kimyasal Ürünler Limited Şirketi Turkey⁸
Chemours Titanium Technologies (Taiwan) Ltd. Taiwan⁸
Chemours UK Limited United Kingdom⁸
Chemours Vietnam Company Limited Vietnam⁸
FT Chemical, Inc. Texas⁸
First Chemical Holdings, LLC Mississippi⁸
First Chemical Texas, L.P Delaware⁸
ICOR International Inc. Indiana⁸
Initiatives Inc de México S.A. de C.V. Mexico⁸

All 51 listed subsidiaries

Noluma International, LLC Delaware⁸
PT The Chemours Indonesia Indonesia⁸
Southern Ionics Minerals, LLC Mississippi⁸
The Chemours (Changshu) Fluoro Technology Company Limited China⁸
The Chemours (Taiwan) Company Limited Taiwan⁸
The Chemours (Thailand) Company Limited Thailand⁸
The Chemours 3F Fluorochemicals (Changshu) Company, Limited China⁸
The Chemours Canada Company Canada⁸
The Chemours Chemical (Shanghai) Company Limited China⁸
The Chemours China Holding Co., Ltd. China⁸
The Chemours Company (Argentina) S.R.L. Argentina⁸
The Chemours Company (Australia) Pty Ltd Australia⁸
The Chemours Company AR, LLC Delaware⁸
The Chemours Company Asia Pacific Operations, Inc. Delaware⁸
The Chemours Company Delaware Operations, Inc. Delaware⁸
The Chemours Company FC, LLC Delaware⁸
The Chemours Company Holding US, LLC Delaware⁸
The Chemours Company Industria E Comercio de Produtos Quimicos Ltda. Brazil⁸
The Chemours Company Mexicana S. de R.L. de C.V. Mexico⁸
The Chemours Company Mexico, S. de R.L. de C.V. Mexico⁸
The Chemours Company North America, Inc. Delaware⁸
The Chemours Company Servicios, S. de R.L. de C.V. Mexico⁸
The Chemours Company Singapore Pte. Ltd. Singapore⁸
The Chemours Company Worldwide Operations, Inc. Delaware⁸
The Chemours Holding Company, S. de R.L. de C.V. Mexico⁸
The Chemours India Private Limited India⁸
The Chemours Malaysia Sdn. Bhd. Malaysia⁸

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

Chemours Company, LLCDec 18, 2014 to Apr 21, 2015⁶

Controversies and legal

Legal and regulatory issues

Chemours' plant in Bladen County, North Carolina, was found to be dumping vast quantities of a chemical dubbed "GenX", a precursor of Teflon, into the Cape Fear River. This story is recounted in the 2018 documentary film The Devil We Know, which centers on Parkersburg, West Virginia, where the DuPont facility that manufactured Teflon was located. The documentary follows the personal stories and tribulations of several people who worked at the Parkersburg facility.

In September 2023, a court in the Netherlands found Chemours to be liable for pollution caused by the polytetrafluoroethylene (Teflon) producing plant in Dordrecht, South Holland. The court stated that Chemours' predecessor DuPont had willingly withheld crucial information between 1984 and 1998 about the harmful effects of the substances it used and emitted, which made the pollution unlawful.

PFAS-related settlements: Washington Works, Chambers Works, and other drinking water contamination

Over the course of a century, DuPont was alleged to have dumped 100 million pounds of toxic chemicals into waterways in New Jersey and Delaware from its Chambers Works plant near Carneys Point Township, New Jersey. The property was transferred to Chemours in the corporate spin-off in July 2015. In 2016, Carneys Point Township, New Jersey initiated a $1.1 billion lawsuit against DuPont and Chemours, accusing DuPont of completing the corporate spin-off of Chambers Works into Chemours without first remediating the property as required by law.

In July 2021, Chemours, along with Corteva and DuPont, agreed to a $50 million settlement with Delaware. Chemours's share of the settlement was 50%.

In June 2023, Chemours, along with Corteva and DuPont, agreed to pay $1.2 billion in a national settlement to resolve all PFAS-related drinking water claims. Chemours's share of the settlement was 50%.

In November 2023, Chemours, along with Corteva and DuPont, agreed to a $110 million settlement with Ohio regarding PFAS-related claims, primarily from Washington Works. Chemours's share of the settlement was 50%.

Read the full text

In August 2025, Chemours, along with Corteva and DuPont, agreed to a $2 billion settlement with New Jersey to clean up 4 sites in New Jersey, including 2 industrial sites that discharged PFAS: Parlin and Chambers Works, as well as a shuttered munitions production plant in Pompton Lakes, New Jersey, and a facility that manufactured dynamite in Parlin, New Jersey. The settlement includes an $875 million payment to New Jersey and establishment of a $1.2 billion fund to clean up the 4 sites. Chemours's share of the settlement was 50%.

From Wikipedia’s article on Chemours, shared under CC BY-SA 4.0.⁷

Timeline

Sep 10, 20268-K Entered a material agreement; Regulation FD disclosure⁷⁵
Sep 9, 20268-K Regulation FD disclosure⁷⁶
Aug 4, 20268-K Results of operations⁷⁷
Jun 24, 20268-K Entered a material agreement; Regulation FD disclosure⁷⁸
May 5, 20268-K Results of operations⁷⁹
Apr 30, 20268-K Executive or director change; Shareholder vote⁸⁰
Mar 12, 20268-K Entered a material agreement; New debt or obligation; Other events⁸¹
Feb 26, 20268-K Other events⁸²
Feb 19, 20268-K Results of operations⁸³
Jan 16, 20268-K Entered a material agreement; Regulation FD disclosure⁸⁴
Nov 6, 20258-K Results of operations⁸⁵
Oct 31, 20258-K Executive or director change⁸⁶
Mar 5, 2024New chief executive Denise Dignam becomes CEO²⁰
Jun 17, 2015New chief executive Mark P. Vergnano becomes CEO²¹
2015Founded Founded¹

Calendar

Coming up

Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $0.20 a share, on Nov 6, 2025.⁸⁷

When it reported results

Aug 4, 2026Reported quarterly or annual results⁷⁷
May 5, 2026Reported quarterly or annual results⁷⁹
Feb 19, 2026Reported quarterly or annual results⁸³
Nov 6, 2025Reported quarterly or annual results⁸⁵
Aug 5, 2025Reported quarterly or annual results⁸⁸
May 6, 2025Reported quarterly or annual results⁸⁹
Feb 18, 2025Reported quarterly or annual results⁹⁰
Nov 4, 2024Reported quarterly or annual results⁹¹

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

440 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 89 major events, 250 insider forms, 30 large holders, 51 other. The latest 20:

Oct 1, 20264 EDGAR
Sep 10, 20268-K EDGAR
Sep 9, 20268-K EDGAR
Aug 13, 20264 EDGAR
Aug 13, 20264 EDGAR
Aug 13, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 11, 20264 EDGAR
Aug 10, 20264 EDGAR
Aug 10, 20264 EDGAR
Aug 5, 202610-Q EDGAR
Aug 4, 20268-K EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Aug 4, 20264 EDGAR
Jul 1, 20264 EDGAR
Jun 24, 20268-K EDGAR

The 440 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

32 open-market trades by officers, directors and large owners since October 2021: 13 buys and 19 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Aug 12, 2026	Familiar Calderon GerardoSee Remarks	Buy	1,935	$15.53	$30.1K	Form 4
Aug 11, 2026	Dignam DeniseChief Executive Officer	Buy	3,378	$14.95	$50.5K	Form 4
Aug 7, 2026	Cowan AlisterDirector	Buy	13,000	$15.62	$203.1K	Form 4
Aug 7, 2026	Foley Michael RobertSee Remarks	Buy	1,934	$15.51	$30.0K	Form 4
Aug 7, 2026	Martinko Joseph T.See Remarks	Buy	1,940	$15.47	$30.0K	Form 4
Aug 7, 2026	CRANSTON MARY BDirector	Buy	6,000	$15.83	$95.0K	Form 4
Aug 6, 2026	HOSTETTER SHANEChief Financial Officer	Buy	3,350	$14.94	$50.0K	Form 4
Aug 8, 2025	Dignam DeniseChief Executive Officer	Buy	4,068	$12.06	$49.1K	Form 4
Jun 3, 2025	Gumpel DamianSee Remarks	Buy	7,822	$9.95	$77.8K	Form 4
Jun 2, 2025	Gumpel DamianSee Remarks	Buy	13,400	$9.22	$123.5K	Form 4
May 19, 2025	HOSTETTER SHANEChief Financial Officer	Buy	4,450	$11.28	$50.2K	Form 4
Nov 7, 2024	Scarborough AlveniaSVP Corp Communications & CBO	Sale	7,500	$20.64	$154.8K	Form 4
Aug 7, 2024	Picho Diane I.See Remarks	Sale	2,684	$18.82	$50.5K	Form 4
Aug 6, 2024	Picho Diane I.See Remarks	Sale	73	$19.04	$1.4K	Form 4
Jun 9, 2023	Scarborough AlveniaSVP Corp Communications & CBO	Sale	5,125	$32.30	$165.5K	Form 4
Jun 9, 2023	Newman MarkPresident and CEO	Buy	7,661	$32.63	$250.0K	Form 4
Jun 9, 2023	Newman MarkPresident and CEO	Buy	7,661	$34.63	$265.3K	Form 4
Jun 8, 2023	Abbott Matthew SSVP, Chief Ent. Transf. Ofc.	Sale	8,912	$34.20	$304.8K	Form 4
Mar 6, 2023	Bellezza AlishaPresident, Thermal Spec Solns	Sale	27,716	$35.47	$983.1K	Form 4
Jun 7, 2022	Sparks Edwin CPresident, Titan Tech Chem Sol	Sale	22,142	$43.59	$965.2K	Form 4

All 32 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 2026⁹²
VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 2026⁹³
BlackRockSCHEDULE 13G/A, 8 filings Feb 3, 2022 to Apr 24, 2026⁹⁴
VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 9, 2022 to Mar 26, 2026⁹⁵
MILLENNIUM MANAGEMENT LLCSCHEDULE 13G/A, 2 filings Jun 10, 2025 to Aug 8, 2025⁹⁶
FMR LLCSCHEDULE 13G/A, 10 filings Nov 10, 2021 to Aug 6, 2025⁹⁷
Sessa Capital (Master), L.P.SC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 2023⁹⁸

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

Year	Executive	Salary	Total pay
2025	Denise DignamPresident and Chief Executive Officer	$1.1M	$8.6M⁹⁹
2025	Shane HostetterSenior Vice President, Chief Financial Officer	$646.8K	$2.7M⁹⁹
2025	Kristine WellmanSenior Vice President, General Counsel and Corporate Secretary	$591.9K	$2.0M⁹⁹
2025	Joseph MartinkoPresident, Thermal & Specialized Solutions	$542.1K	$1.7M⁹⁹
2025	Gerardo FamiliarPresident, Advanced Performance Materials	$535.8K	$1.5M⁹⁹
2024	Denise DignamPresident and Chief Executive Officer	$904.2K	$5.9M⁹⁹
2024	Kristine WellmanSenior Vice President, General Counsel and Corporate Secretary	$541.7K	$1.8M⁹⁹
2024	Joseph MartinkoPresident, Thermal & Specialized Solutions	$473.3K	$1.4M⁹⁹
2024	Gerardo FamiliarPresident, Advanced Performance Materials	$473.3K	$1.4M⁹⁹
2024	Shane HostetterSenior Vice President, Chief Financial Officer	$305.0K	$1.0M⁹⁹
2023	Denise DignamPresident and Chief Executive Officer	$531.7K	$2.2M⁹⁹
2023	Kristine WellmanSenior Vice President, General Counsel and Corporate Secretary	$491.7K	$1.4M⁹⁹

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
BlackRock, Inc.	23,283,074	$477.8M	0.0%	+897,224
Vanguard Portfolio Management LLC	10,568,867	$216.9M	0.0%	+243,526
Vanguard Capital Management LLC	6,784,588	$139.2M	0.0%	+10,671
State Street Corp	6,115,375	$125.5M	0.0%	−7,713
Ameriprise Financial Inc	4,924,004	$101.0M	0.0%	+86,201
American Century Companies Inc	4,379,525	$89.9M	0.0%	−36,339
Jpmorgan Chase & Co	4,199,395	$85.2M	0.0%	+398,522
Geode Capital Management, LLC	3,823,361	$78.5M	0.0%	+219,440
Voya Investment Management LLC	3,544,702	$72.7M	0.1%	+3,502,649
Wolf Hill Capital Management, LP	2,909,262	$59.7M	5.8%	−780,532
D. E. Shaw & Co., Inc.	2,870,039	$58.9M	0.0%	+19,029
Dimensional Fund Advisors LP	2,771,370	$56.9M	0.0%	+537,080
Highland Peak Capital, LLC	2,641,589	$54.2M	15.8%	+1,183,210
UBS Group AG	2,593,745	$53.2M	0.0%	−174,061
Goldman Sachs Group Inc	2,552,439	$52.4M	0.0%	−461,675
Charles Schwab Investment Management Inc	2,044,387	$42.0M	0.0%	−109,262
Vision One Management Partners, LP	1,720,189	$35.3M	12.7%	No change
Northern Trust Corp	1,657,540	$34.0M	0.0%	+91,715
Morgan Stanley	1,641,305	$33.7M	0.0%	−162,397
Nuveen, LLC	1,633,838	$33.5M	0.0%	+1,270,368
Bank of New York Mellon Corp	1,625,379	$33.4M	0.0%	+15,081
Legal & General Group Plc	1,384,024	$28.4M	0.0%	−710,833
Two Sigma Investments, LP	1,362,389	$28.0M	0.0%	+367,686
Marshall Wace, Llp	1,191,775	$24.5M	0.0%	−61,508
Vanguard Fiduciary Trust Co	1,086,496	$22.3M	0.0%	+43,180

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

3 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Aug 9, 2023	Michael C. Burgess, House	Buy	$15,001 - $50,000	−137.4%	Report
Jul 6, 2023	Michael C. Burgess, House	Buy	$15,001 - $50,000	−140.1%	Report
Jul 6, 2023	Michael C. Burgess, House	Partial sale	$1,001 - $15,000	+140.1%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Chemours is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARChemours Co²
CIK0001627223
Employer ID (EIN)46-4845564¹⁹
Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company¹⁹
Incorporated inDelaware¹⁹
Fiscal year endsDecember 31²
Industry code (SIC)2800 Chemicals & Allied Products²
SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance²
Business address1007 Market Street, Wilmington, DE 19801²
Phone302 773 1000²
Shares outstanding150,498,995 as of Jul 30, 2026¹⁶
Public float$1.7B as of Jun 30, 2025¹⁹
AuditorPricewaterhouseCoopers LLP, Philadelphia, Pennsylvania PCAOB ID 238; it also attests to the company’s internal control over financial reporting¹⁹
On EDGAR sinceDec 18, 2014²
Filings1,000 in all: 4 (520), 8-K (182), 3 (51), SC 13G/A (37), 10-Q (34), 4/A (21), 144 (18), DEFA14A (18)²
All 38 form types
UPLOAD (12), 10-K (11), CORRESP (11), DEF 14A (11), SCHEDULE 13G/A (10), SD (10), 8-K/A (7), S-8 (6), SC 13G (6), 10-12B/A (4), ARS (4), 424B5 (3), PRE 14A (3), SCHEDULE 13G (3), EFFECT (2), FWP (2), 10-12B (1), 10-Q/A (1), 3/A (1), 424B2 (1), 424B3 (1), CERTNYS (1), NO ACT (1), NT 10-K (1), POS AM (1), POSASR (1), PX14A6G (1), S-3ASR (1), S-4 (1), S-4/A (1)
Latest filingsAnnual report (10-K) Feb 24, 2026
Quarterly report (10-Q) Aug 5, 2026
Proxy statement (DEF 14A) Mar 10, 2026
Latest 8-K (8-K) Sep 10, 2026

Securities registered for trading

Class	Symbol	Exchange
Common Stock ($0.01 par value)	CC	New York Stock Exchange

From the cover page of the 10-K filed Feb 24, 2026 (Section 12(b) of the Exchange Act).¹⁹

Risk factors and legal proceedings

The risks Chemours names in Item 1A of its 10-K filed Feb 24, 2026: 40 risks under these headings, as written.¹⁹

Our operations could be affected by various risks, many of which are beyond our control. Based on current information, we believe that the following identifies the material risk factors that could affect our business, results of operations, or financial condition. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. Refer to our “Forward-looking Statements” for more details.
Risks Related to Legal Matters, Environmental Sustainability, and Regulations
Risks Related to Our Business Performance
Risks Related to Our Operations
Risks Related to Our Indebtedness
General Risk Factors
Our results of operations could be adversely affected by litigation and other commitments and contingencies.
We are subject to extensive environmental and health and safety laws and regulations that may result in unanticipated loss or liability related to our current and past operations, or our ability to place our products in the market, and that may result in significant additional compliance costs or obligations, which in either case, could reduce our profitability or liquidity.
In connection with our Separation, we were required to enter into numerous Separation-related and commercial agreements with our former parent company, EID, which may not reflect optimal or commercially beneficial terms to us.
If the distribution, in connection with the Separation, together with certain related transactions, were to fail to qualify for non-recognition treatment for U.S. federal income tax purposes, then we could be subject to significant tax and indemnification liability and stockholders receiving our common stock in the distribution could be subject to significant tax liability.
As a result of the audit committee internal review in 2024, we may be exposed to civil and criminal litigation from investors and/or regulatory entities and significant financial and operational costs, which may adversely affect our reputation, results of operations, financial condition, and cash flows.
Our failure to comply with the anti-corruption laws of the U.S. and various international jurisdictions could negatively impact our reputation and results of operations, financial condition, and cash flows.

The other 33 risks

The current geopolitical environment has led to rapidly changing economic sanctions issued by the United States against individuals, entities and countries and resulted in countermeasures imposed by other jurisdictions. Failure to detect and abide by these changes could impact our reputation and results of operations, financial condition, and cash flows.
Operating as a multi-national corporation presents risks associated with global and regional economic, political and global capital market conditions, as well as risks resulting from changes to regional regulatory requirements (including environmental standards).
If we are unable to innovate and successfully introduce new products, or new technologies or processes reduce the demand for our products or the price at which we can sell products, our profitability could be adversely affected.
If significant tariffs or other restrictions continue to be placed on foreign imports by the United States and related countermeasures are taken by impacted foreign countries, our results of operations could be negatively affected.
The emergence, renegotiation, or expiration of FTAs and other international trade frameworks could adversely affect our competitiveness, supply chain, and financial results.
The businesses in which we compete are highly competitive. If our intellectual property were compromised or copied by competitors, or if our competitors were to develop similar or superior intellectual property or technology, our results of operations could be negatively affected.
Effects of price fluctuations in energy and raw materials, our raw materials contracts, and our inability to renew such contracts, could have a significant negative impact on our operating results
Our reported results and financial condition could be adversely affected by currency exchange rates and currency devaluation could impair our competitiveness.
If our long-lived assets, including goodwill, become impaired, we may be required to record significant charges to earnings.
We could be subject to changes in our tax rates and the adoption of tax legislation or exposure to additional tax liabilities that may adversely affect our results of operations, financial condition, and cash flows.
We are subject to continuing contingent tax-related liabilities of EID.
We are a holding company that is dependent on cash flows from our operating subsidiaries to fund our debt obligations, MOU escrow funding requirements, capital expenditures, and ongoing operations.
Failure to meet some or all of our key financial and non-financial targets could negatively impact the value of our business and adversely affect our stock price.
A pandemic, epidemic, or other outbreak of infectious disease may have a material adverse effect on our business operations, results of operations, financial condition, and cash flows.
Our ability to make future strategic decisions regarding our manufacturing operations are subject to regulatory, environmental, political, legal, and economic risks, and to a certain extent may be subject to consents or cooperation from EID under the agreements entered into between us and EID as part of the Separation. These could adversely affect our ability to execute our future strategic decisions and our results of operations, financial condition, and cash flows.
Hazards associated with chemical manufacturing, storage, containment, and transportation could adversely affect our results of operations.
Our results of operations and financial condition could be seriously impacted by business disruptions, including environmental, weather, and natural disasters, as well as other events outside of our control.
We participate in certain business relationships where we may be adversely impacted by the actions of the joint venture, its participants, or other partners.
Our results of operations and financial condition could be seriously impacted by business disruptions and security breaches, including cybersecurity incidents.
Our use of new and evolving technologies, including AI, may present risks and challenges that could adversely impact our business, competitive position, and financial condition.
Our operations could be materially impacted in the event of a failure of our information technology infrastructure.
If we identify a material weakness in internal control over financial reporting, or if we fail to maintain an effective system of internal controls, we may not be able to accurately determine our financial results or prevent fraud, either of which could have a material effect on us.
Our success depends on our ability to attract and retain key employees, and to identify and develop talented personnel to succeed our senior management key employees or members of our board of directors.
Our current level of indebtedness could adversely affect our financial condition or liquidity, and we could have difficulty fulfilling our obligations under our indebtedness, which may have a material adverse effect on us.
Despite our current level of indebtedness, we may incur substantially more debt and enter into other transactions, which could further exacerbate the risks to our financial condition described above.
We may need additional capital in the future and may not be able to obtain it on favorable terms, or at all.
The agreements governing our indebtedness restrict our current and future operations, particularly our ability to respond to changes or to take certain actions.
Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
Adverse developments affecting the financial markets and currency exchange rates, including events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our business, financial condition, results of operations or cash flows.
Our stock price could become more volatile and investments could lose value.
We cannot guarantee the timing or amount of our dividends, if any, and/or our share repurchases, which are subject to a number of uncertainties that may affect the price of our common stock.
A stockholder’s percentage of ownership in us may be diluted in the future.
Certain provisions in our amended and restated certificate of incorporation and amended and restated by-laws, and of Delaware law, may prevent or delay an acquisition of us, which could decrease the trading price of the common stock.

Legal proceedings

We are subject to various legal proceedings, including, but not limited to, product liability, intellectual property, personal injury, commercial, contractual, employment, governmental, environmental and regulatory, anti-trust, and other such matters that arise in the ordinary course of business. In addition, we, by virtue of our status as a subsidiary of EID prior to the Separation, are subject to or required under the Separation-related agreements executed prior to the Separation to indemnify EID against various pending legal proceedings. Discussion of all legal and environmental proceedings is incorporated by reference from Part II, Item 8, "Note 22 - Commitments and Contingent Liabilities” of this document, and should be considered an integral part of Part I, Item 3, “Legal Proceedings.”

The opening of Item 3, Legal Proceedings.¹⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataChemours on Wikidata
2
SEC EDGARChemours filings on SEC EDGAR
3
WikipediaChemours on Wikipedia
4
GLEIFChemours LEI record (549300M1BOLNXL8DOV14)
5
Wikimedia CommonsChemours logo by Unknown author Unknown author, Public domain
6
SEC EDGARChemours filings on SEC EDGAR
7
WikipediaChemours on Wikipedia (revision used)
8
SEC EDGARChemours annual report, Exhibit 21 (subsidiaries)
9
Wikimedia CommonsChemours photo by Suyash.dwivedi, CC BY-SA 4.0
10
SEC EDGARChemours 10-K for fiscal 2025
11
SEC EDGARChemours 10-K for fiscal 2019
12
SEC EDGARChemours 10-K for fiscal 2020
13
SEC EDGARChemours 10-K for fiscal 2021
14
SEC EDGARChemours 10-K for fiscal 2022
15
SEC EDGARChemours 10-Q for fiscal 2026
16
SEC EDGARChemours 10-Q for fiscal 2026
17
SEC EDGARChemours 10-K for fiscal 2019
18
SEC EDGARChemours 10-K for fiscal 2019
19
SEC EDGARChemours 10-K filed Feb 24, 2026: Item 2, Properties
20
SEC EDGARDenise Dignam, Chief executive officer
21
SEC EDGARMark P. Vergnano, Chief executive officer
22
SEC EDGARJoseph T. Martinko, President
23
SEC EDGARAlisha Bellezza, President
24
SEC EDGARDenise Dignam, President
25
SEC EDGAREdwin C. Sparks, President
26
SEC EDGARPaul Kirsch, President
27
SEC EDGARMichael P. Heffernan, President
28
SEC EDGARE. Bryan Snell, President
29
SEC EDGARMark P. Vergnano, President
30
SEC EDGARThierry Fj Vanlancker, President
31
SEC EDGARChristian W. Siemer, President
32
SEC EDGARMatthew S. Abbott, Chief financial officer
33
SEC EDGARShane Hostetter, Chief financial officer
34
SEC EDGARSameer Ralhan, Chief financial officer
35
SEC EDGARDamian Gumpel, Officer
36
SEC EDGARJoseph T. Martinko, Officer
37
SEC EDGARDiane I. Picho, Interim Pres. - Titanium Tech
38
SEC EDGARDavid Will, Chief Accounting Officer
39
SEC EDGARCalderon Gerardo Familiar, Pres Advanced Performance Mat
40
SEC EDGARDenise Dignam, SVP, President, Titanium Techn
41
SEC EDGARRon Christopher Charles, Senior Vice President, People
42
SEC EDGARKristine M. Wellman, SVP, GC & Corp. Secretary
43
SEC EDGARCamela Wisel, VP, CAO & Controller
44
SEC EDGARJonathan Lock, SVP, Chief Development Officer
45
SEC EDGARAlvenia Scarborough, SVP Corp Communications & CBO
46
SEC EDGARMatthew S. Abbott, VP, CAO & Controller
47
SEC EDGARSusan M. Kelliher, Senior VP of Human Resources
48
SEC EDGARPaul Kirsch, Pres Fluoroproducts(Designate)
49
SEC EDGARAmy Trojanowski, Controller (Designate)
50
SEC EDGARChristian W. Siemer, Pres Chem Solution (Designate)
51
SEC EDGARDavid C. Shelton, GC and Corp. Sec. (Designate)
52
SEC EDGARE. Bryan Snell, Pres Titanium Tech (Designate)
53
SEC EDGARElizabeth Albright, Sr. VP - HR (Designate)
54
SEC EDGARErich Parker, VP Corp Comm & CBO (Desginate)
55
SEC EDGARNigel Pond, VP & Asst. Treasurer
56
SEC EDGARSteven Zelac, Vice President
57
SEC EDGARThierry Fj Vanlancker, Pres Fluoroproduct (Designate)
58
SEC EDGARJoseph Daniel Kava, Board member
59
SEC EDGARLeslie M. Turner, Board member
60
SEC EDGARCourtney Mather, Board member
61
SEC EDGARGeorge R. Brokaw, Board member
62
SEC EDGARDenise Dignam, Board member
63
SEC EDGARLivingston Satterthwaite, Board member
64
SEC EDGARAlister Cowan, Board member
65
SEC EDGARSandra L. Phillips, Board member
66
SEC EDGARErin N. Kane, Board member
67
SEC EDGARSean D. Keohane, Board member
68
SEC EDGARCurtis J. Crawford, Board member
69
SEC EDGARBradley J. Bell, Board member
70
SEC EDGARCurt Anastasio, Board member
71
SEC EDGARDawn L. Farrell, Board member
72
SEC EDGARMary B. Cranston, Board member
73
SEC EDGARRichard H. Brown, Board member
74
SEC EDGARStephen D. Newlin, Board member
75
SEC EDGAREntered a material agreement; Regulation FD disclosure
76
SEC EDGARRegulation FD disclosure
77
SEC EDGARResults of operations
78
SEC EDGAREntered a material agreement; Regulation FD disclosure
79
SEC EDGARResults of operations
80
SEC EDGARExecutive or director change; Shareholder vote
81
SEC EDGAREntered a material agreement; New debt or obligation; Other events
82
SEC EDGAROther events
83
SEC EDGARResults of operations
84
SEC EDGAREntered a material agreement; Regulation FD disclosure
85
SEC EDGARResults of operations
86
SEC EDGARExecutive or director change
87
NasdaqNasdaq calendar
88
SEC EDGARChemours 8-K, Item 2.02 (results of operations)
89
SEC EDGARChemours 8-K, Item 2.02 (results of operations)
90
SEC EDGARChemours 8-K, Item 2.02 (results of operations)
91
SEC EDGARChemours 8-K, Item 2.02 (results of operations)
92
SEC EDGARVANGUARD CAPITAL MANAGEMENT LLC SCHEDULE 13G on Chemours
93
SEC EDGARVANGUARD PORTFOLIO MANAGEMENT LLC SCHEDULE 13G on Chemours
94
SEC EDGARBlackRock SCHEDULE 13G/A on Chemours
95
SEC EDGARVANGUARD GROUP INC SCHEDULE 13G/A on Chemours
96
SEC EDGARMILLENNIUM MANAGEMENT LLC SCHEDULE 13G/A on Chemours
97
SEC EDGARFMR LLC SCHEDULE 13G/A on Chemours
98
SEC EDGARSessa Capital (Master), L.P. SC 13G/A on Chemours
99
SEC EDGARChemours proxy statement (DEF 14A), 2025 pay